The SMA gene replacement therapy developed by the Mendell and Kaspar teams at Nationwide Children's Hospital and collaborators at Ohio State University has the realistic potential to cure a devastating neurological disorder of newborn infants.
Not exact matches
«Encouraging data for
gene replacement therapy for
SMA type I, phase 1 study shows.»
Hereditary diseases like
SMA maybe a prime therapeutic indications for
gene therapy, where
gene therapy will provide a functional
replacement for a dysfunctional
gene.